|
Volumn 64, Issue 5, 2016, Pages 1825-1827
|
Treating hepatitis B virus/hepatitis C virus coinfected patients with direct-acting hepatitis C virus antivirals only is not safe
a b c d b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ANTIVIRUS AGENT;
BILIRUBIN;
HEPATITIS B CORE ANTIBODY;
HEPATITIS B SURFACE ANTIGEN;
IMMUNOGLOBULIN G;
RIBAVIRIN;
SIMEPREVIR;
SOFOSBUVIR;
TENOFOVIR;
ADULT;
CASE REPORT;
DRUG SAFETY;
FEMALE;
HEPATITIS B;
HEPATITIS B VIRUS;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
INTERNATIONAL NORMALIZED RATIO;
LETTER;
LIVER FAILURE;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
MIXED INFECTION;
PRIORITY JOURNAL;
VIRUS REACTIVATION;
VIRUS REPLICATION;
AGED;
DRUG EFFECTS;
HEPACIVIRUS;
AGED;
ANTIVIRAL AGENTS;
COINFECTION;
FEMALE;
HEPACIVIRUS;
HEPATITIS B;
HEPATITIS C;
HUMANS;
MALE;
MIDDLE AGED;
|
EID: 84971273097
PISSN: 02709139
EISSN: 15273350
Source Type: Journal
DOI: 10.1002/hep.28592 Document Type: Letter |
Times cited : (5)
|
References (4)
|